Literature DB >> 17678915

Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis.

Cleophas M Kyama1, Lutgart Overbergh, Attila Mihalyi, Christel Meuleman, Jason M Mwenda, Chantal Mathieu, Thomas M D'Hooghe.   

Abstract

OBJECTIVE: To examine messenger (m) RNA expression of aromatase, cytokines, and adhesion factors in women with and without endometriosis.
DESIGN: Patients with endometriosis were compared with control patients.
SETTING: University Hospital Gasthuisberg, Leuven, Belgium. PATIENT(S): A total of 35 patients who had laparoscopic surgery during the luteal phase (n = 20) or the menstrual phase (n = 15) were selected for this study based on cycle phase and presence/absence of endometriosis. INTERVENTION(S): Tissues of endometrium and macroscopically normal peritoneum were collected during hysteroscopy and laparoscopic surgery, respectively, from 24 women with revised American Society for Reproductive Medicine stage (rASRM) stages I-II (n = 12) and III-IV (n = 12) endometriosis and 11 control patients with normal pelvic. Tissue samples were selected from a tissue bank, based on the phase of the cycle (menstrual or luteal) and the presence/absence of endometriosis. MAIN OUTCOME MEASURE(S): The mRNA levels of aromatase, vimentin, vascular cell adhesion molecule 1 (VCAM-1), alpha(V) and beta(3) integrins, interleukin (IL)-1 beta, regulated on activation normal T-cell expressed and secreted (RANTES), and monocyte chemotactic protein 1 (MCP-1) were evaluated using real-time reverse transcriptase polymerase chain reaction. RESULT(S): During menstrual phase, increased endometrial mRNA levels of alpha(V) integrin, combined alpha(V)beta(3) integrins, and increased peritoneal IL-1 beta mRNA levels--but decreased peritoneal MCP-1 mRNA levels--were observed in women with endometriosis compared with control subjects. During luteal phase, endometrial mRNA levels of IL-1 beta and RANTES were increased in women with endometriosis compared with control subjects. Endometrial aromatase mRNA expression was higher in women with endometriosis than in control subjects in combined phases. Women with endometriosis had increased peritoneal mRNA expression of RANTES and VCAM-1 during menstrual compared with luteal phase. CONCLUSION(S): Aberrant mRNA expression of aromatase, cytokines, and adhesion factors in endometrium and peritoneum suggests that both tissues are involved in the pathogenesis of endometriosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17678915     DOI: 10.1016/j.fertnstert.2007.02.057

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  28 in total

Review 1.  Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects.

Authors:  Jian-Jun Wei; Josette William; Serdar Bulun
Journal:  Int J Gynecol Pathol       Date:  2011-11       Impact factor: 2.762

Review 2.  Endometriosis: pathogenesis and treatment.

Authors:  Paolo Vercellini; Paola Viganò; Edgardo Somigliana; Luigi Fedele
Journal:  Nat Rev Endocrinol       Date:  2013-12-24       Impact factor: 43.330

Review 3.  Endometrial biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Devashana Gupta; M Louise Hull; Ian Fraser; Laura Miller; Patrick M M Bossuyt; Neil Johnson; Vicki Nisenblat
Journal:  Cochrane Database Syst Rev       Date:  2016-04-20

4.  The Influence Mechanism of Abnormal Immunophilin FKBP52 on the Expression Levels of PR-A and PR-B in Endometriosis Based on Endometrial Stromal Cell Model in Vitro.

Authors:  Liling Liu; Junping Cheng; Fu Wei; Lihong Pang; Zhifu Zhi; Wenmei Yang; Weihong Tan
Journal:  Organogenesis       Date:  2021-01-19       Impact factor: 2.500

Review 5.  Traditional Chinese medicine prescription Guizhi Fuling Pills in the treatment of endometriosis.

Authors:  Xin Wang; Yaxin Shi; Li Xu; Zilu Wang; Yanfei Wang; Wei Shi; Ke Ma
Journal:  Int J Med Sci       Date:  2021-04-16       Impact factor: 3.738

Review 6.  Is abnormal eutopic endometrium the cause of endometriosis? The role of eutopic endometrium in pathogenesis of endometriosis.

Authors:  Haiyuan Liu; Jing He Lang
Journal:  Med Sci Monit       Date:  2011-04

Review 7.  The emerging use of aromatase inhibitors for endometriosis treatment.

Authors:  Warren B Nothnick
Journal:  Reprod Biol Endocrinol       Date:  2011-06-21       Impact factor: 5.211

Review 8.  PPARγ Agonists: Emergent Therapy in Endometriosis.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Alain Le Blanche; Yves Lecarpentier
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-06

9.  Priorities for endometriosis research: recommendations from an international consensus workshop.

Authors:  Peter A W Rogers; Thomas M D'Hooghe; Asgerally Fazleabas; Caroline E Gargett; Linda C Giudice; Grant W Montgomery; Luk Rombauts; Lois A Salamonsen; Krina T Zondervan
Journal:  Reprod Sci       Date:  2009-02-05       Impact factor: 3.060

10.  Interplay between Misplaced Müllerian-Derived Stem Cells and Peritoneal Immune Dysregulation in the Pathogenesis of Endometriosis.

Authors:  Antonio Simone Laganà; Emanuele Sturlese; Giovanni Retto; Vincenza Sofo; Onofrio Triolo
Journal:  Obstet Gynecol Int       Date:  2013-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.